MedPlus Health saw its shares rise by 5% in morning trade after the company reported a steady performance in its Q4 FY25 results. As of 9:33 AM, the shares were trading 4.74% higher at Rs 994.20.
The pharmaceutical retail chain posted modest revenue growth, with consolidated revenue increasing 1.3% year-on-year to ₹1,510 crore from ₹1,490 crore in the same quarter last year.
The company also reported a significant improvement in operating profitability. EBITDA for the quarter rose to ₹136 crore, marking a 29% increase compared to ₹106 crore in Q4 FY24. This resulted in an EBITDA margin of 9%, up from 7.1% in the previous year.
Net profit for the quarter grew by 53.7% to ₹51.3 crore, compared to ₹33.4 crore a year ago.
MedPlus Health shares opened at ₹950.10 and, at the time of writing, touched a high of ₹1,045.30, also marking the new 52-week high. The day’s low remained at ₹950.10, showing strong buying interest from investors. With the previous 52-week low at ₹616.00, the stock has seen significant upward movement.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
